Pharmaceutical Technology10d
USPTO allows patents for Remedy’s large hemispheric infarction drug
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating ...
Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
Medscape19d
A Case of Acute Ischemic Stroke: Optimizing Management with Penumbra and Vessel Imaging
On arrival (3 h 17 min after symptom onset) the patient remained globally aphasic with dense right hemiparesis and hemisensory loss; her score on the NIH stroke scale was 24, which indicated a ...
ahajournals.org25d
ISC 2025 Session Report: Modernizing Stroke Trials for the 21st Century – Scale, Strategy, and Technology
Stroke research has made remarkable progress over the past few decades, driving significant improvements in patient outcomes. Despite these strides, major challenges remain, including slow recruitment ...